## **Core Concept**
E-cadherin is a transmembrane glycoprotein crucial for cell-cell adhesion, particularly in epithelial tissues. Mutations in the CDH1 gene, which encodes E-cadherin, are associated with a specific subtype of gastric carcinoma. Gastric carcinomas are classified into several types based on their histological and molecular characteristics.

## **Why the Correct Answer is Right**
The correct answer, **D. Diffuse type**, is associated with E-cadherin mutations. The diffuse type of gastric carcinoma is characterized by a lack of glandular formation and a tendency for the cancer cells to infiltrate the stomach wall diffusely. E-cadherin plays a key role in maintaining the structural integrity of epithelial tissues. Mutations in the CDH1 gene lead to the loss of E-cadherin function, resulting in the loss of cell adhesion and the development of diffuse gastric cancer. This subtype is known for its poor prognosis and its association with hereditary diffuse gastric cancer (HDGC), a rare inherited condition.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not correspond to the correct classification related to E-cadherin mutations in gastric carcinoma.
- **Option B:** This option is incorrect as it does not accurately represent the type of gastric carcinoma associated with E-cadherin mutations.
- **Option C:** This option is incorrect because it does not specify the diffuse type of gastric carcinoma, which is the correct association.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that patients with hereditary diffuse gastric cancer (HDGC) due to CDH1 mutations are at a significantly increased risk of developing diffuse gastric cancer, as well as lobular breast cancer. Prophylactic gastrectomy is often considered for individuals with a known CDH1 mutation, given the high risk of gastric cancer and the challenges in detecting it at an early stage.

## **Correct Answer:** D. Diffuse type